After completing my MBA, from IIMA, I joined Dr. Reddy’s in 2013 with focus on the following areas: End-to-end delivery and Nasal and Inhalation portfolio and few super complex generics ($100m+ revenue). Leading a team of statisticians to draw insights needed for product development to shorten the product development cycle. Scoping New Technologies across Pharma, building the right infrastructure, & domain expertise to create platform solution. And leading Top Tier Chemical Engineers’ team to bring industry leading depth of expertise in area of process engineering/Modeling and Simulation/ engineering-based scale up, advanced data analysis [QbD/AI/ML], PAT technologies etc.